Cargando…

The impact and role of hepatic hydrothorax in the prognosis of patients with decompensated cirrhosis: A retrospective propensity score-matched study

BACKGROUND AND AIMS: Hepatic Hydrothorax (HH) is one of the complications in patients with decompensated cirrhosis and its impact and role in the prognosis of patients with decompensated cirrhosis are not yet clear. Thus, this study aimed to determine the role of HH in patients with decompensated ci...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Bo, Shang, Tianling, Huang, Jianjie, Tu, Zhixin, Wang, Yan, Han, Yujin, Wen, Xiaoyu, Jin, Qinglong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485448/
https://www.ncbi.nlm.nih.gov/pubmed/36148461
http://dx.doi.org/10.3389/fmed.2022.904414
_version_ 1784792072109162496
author Ma, Bo
Shang, Tianling
Huang, Jianjie
Tu, Zhixin
Wang, Yan
Han, Yujin
Wen, Xiaoyu
Jin, Qinglong
author_facet Ma, Bo
Shang, Tianling
Huang, Jianjie
Tu, Zhixin
Wang, Yan
Han, Yujin
Wen, Xiaoyu
Jin, Qinglong
author_sort Ma, Bo
collection PubMed
description BACKGROUND AND AIMS: Hepatic Hydrothorax (HH) is one of the complications in patients with decompensated cirrhosis and its impact and role in the prognosis of patients with decompensated cirrhosis are not yet clear. Thus, this study aimed to determine the role of HH in patients with decompensated cirrhosis and the long-term impact on their mortality. MATERIALS AND METHODS: A retrospective study analyzed 624 patients with ascites without pleural effusion in decompensated cirrhosis and 113 patients with HH. Propensity scores were calculated based on eight variables, and the HH and non-HH groups were matched in a 1:1 ratio. The effect and role of HH on the prognosis of patients with decompensated cirrhosis was analyzed using the Kaplan–Meier method and Cox proportional hazards regression model. RESULTS: A total of 737 patients were included. Out of 113 HH patients, 106 could be matched to 106 non-HH patients. After matching, baseline characteristics were well-balanced. The multifactorial Cox proportional hazards model indicated that hepatic encephalopathy and HH were independent risk factors affecting prognostic survival in patients with decompensated cirrhosis (P < 0.01), with risk ratios and 95% confidence intervals (CI) of 2.073 (95% CI: 1.229–3.494, P < 0.01) and 4.724 (95% CI: 3.287–6.789, P < 0.01), respectively. Prognostic survival was significantly worse in the HH group compared to patients in the non-HH group, with mortality rates of 17.9, 30.1, and 59.4% at 6 months, 1 year, and 2 years in the HH group, compared to 0.9, 3.8, and 5.6% in the non-HH group, respectively. The estimated median survival time was 21 (95% CI: 18–25) months in the HH group and 49 (95% CI: 46–52) months in the non-HH group (P < 0.001). CONCLUSION: Hepatic hydrothorax is significantly associated with higher mortality in patients with decompensated cirrhosis and is a highly negligible independent decompensated event affecting their prognosis.
format Online
Article
Text
id pubmed-9485448
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94854482022-09-21 The impact and role of hepatic hydrothorax in the prognosis of patients with decompensated cirrhosis: A retrospective propensity score-matched study Ma, Bo Shang, Tianling Huang, Jianjie Tu, Zhixin Wang, Yan Han, Yujin Wen, Xiaoyu Jin, Qinglong Front Med (Lausanne) Medicine BACKGROUND AND AIMS: Hepatic Hydrothorax (HH) is one of the complications in patients with decompensated cirrhosis and its impact and role in the prognosis of patients with decompensated cirrhosis are not yet clear. Thus, this study aimed to determine the role of HH in patients with decompensated cirrhosis and the long-term impact on their mortality. MATERIALS AND METHODS: A retrospective study analyzed 624 patients with ascites without pleural effusion in decompensated cirrhosis and 113 patients with HH. Propensity scores were calculated based on eight variables, and the HH and non-HH groups were matched in a 1:1 ratio. The effect and role of HH on the prognosis of patients with decompensated cirrhosis was analyzed using the Kaplan–Meier method and Cox proportional hazards regression model. RESULTS: A total of 737 patients were included. Out of 113 HH patients, 106 could be matched to 106 non-HH patients. After matching, baseline characteristics were well-balanced. The multifactorial Cox proportional hazards model indicated that hepatic encephalopathy and HH were independent risk factors affecting prognostic survival in patients with decompensated cirrhosis (P < 0.01), with risk ratios and 95% confidence intervals (CI) of 2.073 (95% CI: 1.229–3.494, P < 0.01) and 4.724 (95% CI: 3.287–6.789, P < 0.01), respectively. Prognostic survival was significantly worse in the HH group compared to patients in the non-HH group, with mortality rates of 17.9, 30.1, and 59.4% at 6 months, 1 year, and 2 years in the HH group, compared to 0.9, 3.8, and 5.6% in the non-HH group, respectively. The estimated median survival time was 21 (95% CI: 18–25) months in the HH group and 49 (95% CI: 46–52) months in the non-HH group (P < 0.001). CONCLUSION: Hepatic hydrothorax is significantly associated with higher mortality in patients with decompensated cirrhosis and is a highly negligible independent decompensated event affecting their prognosis. Frontiers Media S.A. 2022-09-06 /pmc/articles/PMC9485448/ /pubmed/36148461 http://dx.doi.org/10.3389/fmed.2022.904414 Text en Copyright © 2022 Ma, Shang, Huang, Tu, Wang, Han, Wen and Jin. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Ma, Bo
Shang, Tianling
Huang, Jianjie
Tu, Zhixin
Wang, Yan
Han, Yujin
Wen, Xiaoyu
Jin, Qinglong
The impact and role of hepatic hydrothorax in the prognosis of patients with decompensated cirrhosis: A retrospective propensity score-matched study
title The impact and role of hepatic hydrothorax in the prognosis of patients with decompensated cirrhosis: A retrospective propensity score-matched study
title_full The impact and role of hepatic hydrothorax in the prognosis of patients with decompensated cirrhosis: A retrospective propensity score-matched study
title_fullStr The impact and role of hepatic hydrothorax in the prognosis of patients with decompensated cirrhosis: A retrospective propensity score-matched study
title_full_unstemmed The impact and role of hepatic hydrothorax in the prognosis of patients with decompensated cirrhosis: A retrospective propensity score-matched study
title_short The impact and role of hepatic hydrothorax in the prognosis of patients with decompensated cirrhosis: A retrospective propensity score-matched study
title_sort impact and role of hepatic hydrothorax in the prognosis of patients with decompensated cirrhosis: a retrospective propensity score-matched study
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485448/
https://www.ncbi.nlm.nih.gov/pubmed/36148461
http://dx.doi.org/10.3389/fmed.2022.904414
work_keys_str_mv AT mabo theimpactandroleofhepatichydrothoraxintheprognosisofpatientswithdecompensatedcirrhosisaretrospectivepropensityscorematchedstudy
AT shangtianling theimpactandroleofhepatichydrothoraxintheprognosisofpatientswithdecompensatedcirrhosisaretrospectivepropensityscorematchedstudy
AT huangjianjie theimpactandroleofhepatichydrothoraxintheprognosisofpatientswithdecompensatedcirrhosisaretrospectivepropensityscorematchedstudy
AT tuzhixin theimpactandroleofhepatichydrothoraxintheprognosisofpatientswithdecompensatedcirrhosisaretrospectivepropensityscorematchedstudy
AT wangyan theimpactandroleofhepatichydrothoraxintheprognosisofpatientswithdecompensatedcirrhosisaretrospectivepropensityscorematchedstudy
AT hanyujin theimpactandroleofhepatichydrothoraxintheprognosisofpatientswithdecompensatedcirrhosisaretrospectivepropensityscorematchedstudy
AT wenxiaoyu theimpactandroleofhepatichydrothoraxintheprognosisofpatientswithdecompensatedcirrhosisaretrospectivepropensityscorematchedstudy
AT jinqinglong theimpactandroleofhepatichydrothoraxintheprognosisofpatientswithdecompensatedcirrhosisaretrospectivepropensityscorematchedstudy
AT mabo impactandroleofhepatichydrothoraxintheprognosisofpatientswithdecompensatedcirrhosisaretrospectivepropensityscorematchedstudy
AT shangtianling impactandroleofhepatichydrothoraxintheprognosisofpatientswithdecompensatedcirrhosisaretrospectivepropensityscorematchedstudy
AT huangjianjie impactandroleofhepatichydrothoraxintheprognosisofpatientswithdecompensatedcirrhosisaretrospectivepropensityscorematchedstudy
AT tuzhixin impactandroleofhepatichydrothoraxintheprognosisofpatientswithdecompensatedcirrhosisaretrospectivepropensityscorematchedstudy
AT wangyan impactandroleofhepatichydrothoraxintheprognosisofpatientswithdecompensatedcirrhosisaretrospectivepropensityscorematchedstudy
AT hanyujin impactandroleofhepatichydrothoraxintheprognosisofpatientswithdecompensatedcirrhosisaretrospectivepropensityscorematchedstudy
AT wenxiaoyu impactandroleofhepatichydrothoraxintheprognosisofpatientswithdecompensatedcirrhosisaretrospectivepropensityscorematchedstudy
AT jinqinglong impactandroleofhepatichydrothoraxintheprognosisofpatientswithdecompensatedcirrhosisaretrospectivepropensityscorematchedstudy